NWRD09 / Newish Technology - LARVOL DELTA

NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients. (clinicaltrials.gov) - P=N/A | N=18 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd.

New trial • Cervical Cancer • Oncology • Solid Tumor

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer (clinicaltrials.gov) - P=N/A | N=18 | Recruiting | Sponsor: Newish Technology (Beijing) Co., Ltd.

New trial • Cervical Cancer • Oncology • Solid Tumor

Evaluation of NWRD09 for HPV-16 Related Cervical HSIL (clinicaltrials.gov) - P2 | N=156 | Not yet recruiting | Sponsor: Newish Biotech (Wuxi) Co., Ltd.

New P2 trial

NWRD09 for Persistent Cervical HPV16 Infection (clinicaltrials.gov) - P=N/A | N=60 | Recruiting | Sponsor: Newish Biotech (Wuxi) Co., Ltd.

New trial • Infectious Disease

A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region (clinicaltrials.gov) - P1 | N=10 | Recruiting | Sponsor: Newish Biotech (Wuxi) Co., Ltd.

New P1 trial • Infectious Disease